LONDON BROKER RATINGS: Barclays raises NatWest to 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 412.60p on 19-10-2026 at 18:35:13 |
|---|---|
| Change | 6.20p 1.53% |
| Buy | 412.20p |
| Sell | 411.60p |
| Last Trade: | Buy 206,225.00 at 412.60p |
| Day's Volume: | 437,068 |
| Last Close: | 412.60p |
| Open: | 407.00p |
| ISIN: | GB00B2PDGW16 |
| Day's Range | 402.40p - 412.60p |
| 52wk Range: | 345.60p - 712.00p |
| Market Capitalisation: | £620.96m |
| VWAP: | 409.52333p |
| Shares in Issue: | 150.50m |
Wh Smith (SMWH) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 206,225 | 412.60p | Suspected BUY Trade |
16:35:10 - 19-Oct-26 |
| Buy* | 201 | 411.80p | Automatic Execution |
16:29:44 - 19-Oct-26 |
| Buy* | 81 | 411.80p | Automatic Execution |
16:29:44 - 19-Oct-26 |
| Buy* | 30 | 411.80p | Automatic Execution |
16:29:44 - 19-Oct-26 |
| Sell* | 147 | 411.80p | Automatic Execution |
16:29:05 - 19-Oct-26 |
| Sell* | 190 | 411.80p | Automatic Execution |
16:29:05 - 19-Oct-26 |
| Sell* | 100 | 411.80p | Automatic Execution |
16:29:05 - 19-Oct-26 |
| Sell* | 47 | 411.80p | Automatic Execution |
16:29:05 - 19-Oct-26 |
| Buy* | 8 | 412.20p | Automatic Execution |
16:29:04 - 19-Oct-26 |
| Sell* | 190 | 412.00p | Automatic Execution |
16:29:04 - 19-Oct-26 |
Wh Smith (SMWH) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Oct 2026 7:00 am | RNS | Total Voting Rights |
| 16th Sep 2026 7:00 am | RNS | Pre-close Trading Update |
| 1st Sep 2026 7:00 am | RNS | Total Voting Rights |
| 10th Aug 2026 4:27 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 7:00 am | RNS | Total Voting Rights |
| 30th Jun 2026 1:02 pm | RNS | Total Voting Rights |
| 30th Jun 2026 12:59 pm | RNS | Admission to Trading |
| 30th Jun 2026 12:53 pm | RNS | Holding(s) in Company |
| 29th Jun 2026 12:17 pm | RNS | Director/PDMR Shareholding |
| 10th Jun 2026 6:00 pm | RNS | Director/PDMR Shareholding |